AVROBIO, Inc. Intellectual Property Contracts & Agreements
9 Contracts & Agreements
- License Agreements (9 contracts)
- Amendment No. 2 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated January 7, 2020 (Filed With SEC on March 16, 2020)
- Amendment No. 1 to License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated February 21, 2018 (Filed With SEC on March 16, 2020)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on June 11, 2018)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on June 1, 2018)
- Exclusive License Agreement, by and between the Registrant and University Health Network, dated November 4, 2016, as amended (Filed With SEC on June 1, 2018)
- License Agreement, by and between the Registrant and GenStem Therapeutics, Inc., dated October 2, 2017 (Filed With SEC on May 25, 2018)
- Exclusive License Agreement, by and among the Registrant, Stefan Karlsson and Maria Dahl, dated January 30, 2017 (Filed With SEC on May 25, 2018)
- License Agreement, by and between the Registrant and BioMarin Pharmaceutical Inc., dated August 31, 2017 (Filed With SEC on May 25, 2018)
- Exclusive License Agreement, by and between the Registrant and University Health Network, dated November 4, 2016, as amended (Filed With SEC on May 25, 2018)
